| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1 | 2019 | Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer | Lu, R. M. ; Chiu, C. Y.; Liu, I. J.; Chang, Y. L.; Liu, Y. J.; Wu, H. C. | Cancer Science 110(12), 3773-3787 | | | |
2 | 2019 | Antibody-based therapeutics for cancer theranostics | Wu, H. C. | | | | |
3 | 2019 | PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization | Li, MY; Peng, WH; Wu, CH; Chang, YM; Lin, YL; Chang, GD; Wu, HC ; Chen, GC | ONCOGENE 38(44), 7002-7016 | | | |
4 | 2019 | Development of antibody-based theranostics for treatment of cancer | Wu, H. C. | | | | |
5 | 2019 | Dengue and Zika virus domain III-flagellin fusion and glycan- masking E antigen for prime-boost immunization. | Lin, H. H.; Yang, S. P.; Tsai, M. J.; Lin, G. C.; Wu, H. C. ; Wu, S. C. | Theranostics 9(16), 4811-4826 | | | |
6 | 2019 | Development of Targeting Nanoparticles for Cancer Molecular Imaging and Therapy | Wu. H.C. | | | | |
7 | 2019 | The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling | Kuan, I. I.; Chen, C. H.; Lu, J. ; Wu, H. C. | The Journal of Biological Chemistry 294(19), 7769-7786 | | | |
8 | 2019 | Liposomal irinotecan for treatment of colorectal cancer in a preclinical model. | Huang, J. R.; Lee, M. H.; Li, W. S. ; Wu, H. C. | Cancers (Basel) 11(3), 281 | | | |
9 | 2019 | Spectroscopic Micro Imaging Ellipsometry for Studying Effects of Drug Treatment in Colon Cancer Cells | Y-D Chen; C-H Wu; H. Y. Hsu; M. I. Khaleel; Y-C. Chang ; H-C. Wu | International Journal of Precious Engineering Research and Applications 4(1), 9-22 | | | |